Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has The Whole Exome Sequencing Market Growth Evolved From 2024 To 2025, And What’s Ahead?

In recent years, the full exome sequencing market size has seen a rapid expansion. The market is expected to balloon from $2.82 billion in 2024 to $3.36 billion in 2025, displaying a compound annual growth rate (CAGR) of 19.1%. Factors contributing to this historical growth trend include progress in genomic research, the emerging trend of precision medicine, the diagnosis of rare illnesses, applications in pharmaceutical and biotech sectors, as well as a drop in sequencing expenses.

Expectations are high for the whole exome sequencing market size to surge significantly in the coming years. It is projected to escalate to a value of$7.27 billion in 2029″, experiencing a compound annual growth rate (CAGR) of 21.3%. Factors contributing to this growth during the prediction period encompass the widening scope of applications in oncology, incorporation into clinical diagnostics, escalated demand for genetic testing, public genomics initiatives, and the rise of gene therapies. Critical trends during this prediction period encompass improved clinical use and acceptance, the reduction of sequencing costs, a focus on data security and confidentiality, integration with digital health records, and breakthroughs in single-cell sequencing.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10669&type=smp

Which Major Market Drivers Are Expected to Boost the Growth Potential of the Whole Exome Sequencing Market?

The whole exome sequencing market is anticipated to surge due to the escalating prevalence of HIV (human immunodeficiency virus). This virus attacks the human immune system. The technique of whole exome sequencing offers vital insights into the genomic structures of such viruses, enabling personalized treatment and vaccine development for HIV. The Minority HIV/AIDS Fund (MHAF), an American government agency, stated in August 2024, that the estimated number of individuals living with HIV worldwide in 2023 was approximately 39.9 million, including 38.6 million adults and 1.4 million children. This marked a significant increase from previous years. As such, the rising occurrence of HIV is a key contributing factor to the expansion of the whole exome sequencing market.

Which Key Market Segments Comprise the Whole Exome Sequencing Market and Drive Its Revenue Growth?

The whole exome sequencingmarket covered in this report is segmented –

1) By Product: Systems; Kits; Services

2) By Technology: Sequencing By Synthesis; Ion Semiconductor Sequencing; Other Technologies

3) By Application: Diagnostics; Drug Discovery And Development; Personalized Medicine; Agriculture And Animal Research

4) By End-User: Hospitals And Clinics; Pharmaceutical And Biotechnology Companies; Academic and Research Institutes; Clinical Laboratories; Other End-Users

Subsegments:

1) By Systems: Sequencing Systems; Data Analysis Systems

2) By Kits: Library Preparation Kits; Exome Enrichment Kits; Sequencing Kits

3) By Services: Data Analysis Services; Consulting Services; Custom Sequencing Services

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=10669&type=smp

Which Areas Are Leading Regions in the Whole Exome Sequencing Market Expansion Across the Globe?

North America was the largest region in the whole exome sequencing market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global whole exome sequencing market report during the forecast period. The regions covered in the whole exome sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Key Market Trends in theWhole Exome Sequencing Market Over the Coming Years?

The development of novel diagnostic methods is becoming a prevalent trend in the whole exome sequencing industry. Enterprises in this sector are focusing on crafting new unique products in order to maintain their standing in the market. To illustrate, Illumina Inc., an American biotech firm, unveiled NovaSeqX Plus, an incredibly potent sequencing technology in February 2023. The technology combines a high level of accuracy with substantial throughput and incorporates streamlined informatics, sustainability upgrades, and cost-effective sequencing. The advancements incorporated into the NovaSeq X Plus systems are capable of producing tens of thousands of complete genomes annually, thereby enhancing productivity and reducing turnaround time.

View the full report here:

https://www.thebusinessresearchcompany.com/report/whole-exome-sequencing-global-market-report

How Is the Whole Exome Sequencing Market Conceptually Defined?

Whole exome sequencing refers to a genomic sequencing technique in which all of the protein-coding regions in a genome are sequenced. It is used in the laboratory to identify the mutations that may be responsible for a specific disease.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10669

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model